HomeNewsBusinessMoneycontrol ResearchRecent FMCG results marked by volume recovery, should you buy?

Recent FMCG results marked by volume recovery, should you buy?

Dabur’s exceptionally better earnings was due to a recovery in the beverage segment while Emami’s performance came in below our expectation as its summer portfolio lacked shine on account of a weak season

August 08, 2018 / 16:04 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Anubhav Sahu Moneycontrol Research

The quarterly results of FMCG companies indicate revival in consumption in rural areas, albeit on a soft base that was marked by destocking on account of the Goods & Services Tax. Among the recent results, Dabur and Emami are no exception to this trend. Both firms witnessed double-digit volume growth and are outliers in terms of momentum. Dabur’s exceptionally better earnings was due to a recovery in the beverage segment while Emami’s performance came in below our expectation as its summer portfolio lacked shine on account of  a weak season.

Amid this, Tata Global Beverages' earnings was another disappointment, impacted by weak non-branded business.

Story continues below Advertisement

Dabur: Strong volume led growth
Source: Moneycontrol Research

Dabur posted consolidated year-on-year (YoY) sales growth of 16 percent, aided by 21 percent volume growth in the domestic business (68 percent of sales). International operations grew 11 percent on a constant currency basis, underlining recovery in the Middle East North Africa (MENA) market. Domestic business growth broadened last quarter as there was a revival in beverage and homecare segments.

Broadening of volume growth Of late, the beverage segment (foods category constitute 22 percent of sales) has been impacted by high competition, which the management countered by trade promotions, advertising campaigns and new launches. About 27 percent sales growth was aided by a soft base (-8.3 percent sales growth in Q1 FY18). Homecare segment (Odonil, Sanifresh) in the last few quarters witnessed industry-wide weakness. It now seems to be recovering with 17 percent sales growth.

In other categories, the company posted robust numbers aided by the red toothpaste franchise. However, the low-priced category (Babool in case of Dabur) was impacted by promotional offerings from competitors, including the market leader.